Displaying items by tag: division of pulmonary allergy and critical care medicine
UAB was a lead site in the testing of Kalydeco, the first drug to target the underlying genetic causes of cystic fibrosis.
A UAB researcher has received a grant to study idiopathic pulmonary fibrosis.
Tagged under
Tagged under
UAB is the first in the state to offer new procedure that uses thermal energy to help keep airways flowing freely.
Tagged under